Deuterated antimicrobial compounds
AssigneeUniversity of Notre Dame du Lac
InventorsMarvin J. Miller, Viktor Krchnak, Rui Liu
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Notre Dame du Lac
InventorsMarvin J. Miller, Viktor Krchnak, Rui Liu
Estimating the term…
Substituted nitrobenzothiazinones (BTZs) are potent antituberculosis prodrugs that are reductively activated to produce nitroso moieties that form covalent adducts with a cysteine residue of decaprenylphosphoryl-β-D-ribose-2′-oxi-dase (DprE1) of Mycobacterium tuberculosis (Mtb). The resulting cell wall synthesis inhibition is lethal to Mtb, leading to consideration of development of BTZs for clinical use. The hydride-induced reduction of the nitroaromatic proceeds by reversible formation of the corresponding Meisenheimer complex. Herein we demonstrate that chemical reduction of BTZ043 with NaBD4 followed by reoxidation incorporates deuterium into the core nitro aromatic warhead. Subsequent reduction of the deuterated species is not affected, but, as expected, reoxidation is slowed by the deuterium isotope effect, thus prolonging the lifetime of the active nitroso oxidation state.
A method for forming a deuterated compound of Formula IA, IB, or IC:
A method for treating a microbial infection comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula IA, IB, or IC:
A compound of Formula IA, IB, or IC:
Dependencies are inferred from the claim text.